You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

Guideline Objective

The objective of this guideline is to provide clinicians with updated recommendations for prevention and management of chemotherapy-induced nausea and vomiting (CINV) in adult patients, and promote standardized evidence-informed best practices across Ontario.

This update to the 2013 Antiemetic Report is based on current literature, ASCO, NCCN and MASCC/ESMO guidelines, and expert consensus of the Antiemetic Working Group. It includes updates to the recommendations for single-day and multiple-day IV chemotherapy, discussion around cannabinoids, new recommendations for oral chemotherapy and breakthrough CINV, and changes to emetic classification of certain chemotherapy regimens.

Patient Population

Adult patients receiving systemic treatment.

Intended Guideline Users

Clinicians involved in the care of patients receiving systemic treatment (Physicians, Pharmacists, Nurses)





Guideline Identifier: 


Cancer Continuum: 


Type of Content: 

Guidelines & Advice


Authors:  Sarah Salama Kathy Vu David Warr Leta Forbes Daniela Gallo-Hershberg Carlo De Angelis Stephanie Brule Dayna Comfort Lisa Randall Julie Williams Universal Date:  2019-06-01 00:00:00